Will Oncolytics Biotech (TSE:ONC) Spend Its Cash Wisely? [Yahoo! Finance]
Oncolytics Biotech Inc. - Common Shares (ONCY)
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.oncolyticsbiotech.com
Company Research
Source: Yahoo! Finance
For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. So should Oncolytics Biotech TSE:ONC ) shareholders be worried about its cash burn? In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. Check out our latest analysis for Oncolytics Biotech When Might Oncolytics Biotech Run Out Of Money? You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. As at September 2024, Oncolytics Biotech had cash of CA$20m and no debt. In the last year, its cash burn was CA$25m. So it had a cas
Show less
Read more
Impact Snapshot
Event Time:
ONCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCY alerts
High impacting Oncolytics Biotech Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ONCY
News
- Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Oncology in Focus: How Emerging Therapies Are Reshaping Cancer TreatmentPR Newswire
- Oncology in Focus: How Emerging Therapies Are Reshaping Cancer TreatmentPR Newswire
- Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic OutlookGlobeNewswire
- How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
ONCY
Earnings
- 11/12/24 - Miss
ONCY
Sec Filings
- 12/23/24 - Form 6-K
- 12/18/24 - Form 6-K
- 12/3/24 - Form 6-K
- ONCY's page on the SEC website